When was Emerald Therapeutics founded?

Emerald Therapeutics was founded in 2010 and raised its 1st funding round within a year of its incorporation.

Where is Emerald Therapeutics located?

Emerald Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California.

Who is the current CEO of Emerald Therapeutics?

Brian Frezza and D J Kleinbaum s of Emerald Therapeutics. Brian Frezza has also founded 1 company.

How many employees does Emerald Therapeutics have?

As of Oct 31, 2026, the latest employee count at Emerald Therapeutics is 201.

Is Emerald Therapeutics a funded company?

Emerald Therapeutics is a funded company, having raised a total of $39.5M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 22, 2010.

When was the latest funding round of Emerald Therapeutics?

Emerald Therapeutics' latest funding was a $***** Series C round on Jun 2015, with participation from 0 investor.

Where does Emerald Therapeutics rank among its competitors?

Emerald Therapeutics ranks 14th amongst 666 active competitors, of which 60 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Cirdan Imaging, which secured $5.38M in Apr, 2026.

Who are the top competitors of Emerald Therapeutics?

Emerald Therapeutics' top competitors include Ovation, Automata and Tecan. Among them, Cirdan Imaging secured the most recent funding round in April, 2026.

Emerald Therapeutics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Cloud-based remote laboratory automation software for the life sciences industry. The laboratory can be accessed remotely via the Internet where automated robotics conduct experiments, method design, materials logistics, sample preparation, instrument operation, data acquisition and analysis, troubleshooting, waste disposal, and others.

Website: www.emeraldcloudlab.com/
Registered Address: San Francisco, California

Key Metrics

Founded Year

2010

Location

San Francisco, United States

Stage

Series C

Total Funding

$39.5M in 4 rounds

Latest Funding Round

Series C, Jun 2015, $*****

Investors

Founders Fund & 13 more

Ranked

14^th among 666 active competitors

Employee Count

201 as on Oct 31, 2026

Similar Companies

Ovation & 367 more

View Emerald Therapeutics' full profile

Emerald Therapeutics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
EMERALD THERAPEUTICS CIN: 271261333 , United States, Active	Dec 31, 1999	-	187 (As on Dec 31, 2024)	-

Emerald Therapeutics has raised a total funding of $39.5M over 4 rounds. Its first funding round was on Dec 22, 2010. Emerald Therapeutics has 13 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Emerald Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 2015	3748784	Series C	3927927	1817527	1409701	5770599
Feb 20, 2014	4881930	Series B	3186748	2603611	6328855	SciFi & 1 more
Mar 29, 2012	8526152	Series A	7893356	4442472	1185701	6792956

Access funding benchmarks and valuations. Sign up today!

View details of Emerald Therapeutics's funding rounds and investors

The founders of Emerald Therapeutics are Brian Frezza and D J Kleinbaum. D J Kleinbaum and Brian Frezza are the CEOs of Emerald Therapeutics.

Here are the details of Emerald Therapeutics' key team members:

Brian Frezza: Co-Founder & Co-CEO of Emerald Therapeutics.
Contact Info: 1 email address
D J Kleinbaum: Co-Founder & Co-CEO of Emerald Therapeutics.

View details of Emerald Therapeutics's Founder profiles and Board Members

Emerald Therapeutics' employee count trend

Emerald Therapeutics has 201 employees as of Oct 26. Here is Emerald Therapeutics's employee count trend over the years:

Employee count trend for Emerald Therapeutics

Uncover Emerald Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Emerald Therapeutics include Ovation, Automata and Tecan. Here is the list of Top 10 competitors of Emerald Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ovation 2009, Cambridge (United States), Series B	Provider of a cloud-based laboratory information and data management platform for researchers and clinicians	$33.3M	SignalFire, Madrona & 8 others	70/100
2nd	Automata 2015, London (United Kingdom), Series C	Developer of modular lab automation platforms for biological research workflows	$177M	Dimension, Hummingbird Ventures & 26 others	67/100
3rd	Tecan 1980, Mannedorf (Switzerland), Public	Provider of a automated laboratory instruments and solutions	-	Defense.gov, Europa & 2 others	66/100
4th	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
5th	Cirdan Imaging 2010, Lisburn (United Kingdom), Series B	Laboratory Information System for clinical laboratories	$27.6M	Invest Northern Ireland, Kernel Capital & 41 others	65/100
6th	Quartzy 2009, Hayward (United States), Series C	Provider of web-based platform for labs management	$56.9M	Eminence Capital, Orthogonal Thinker & 20 others	64/100
7th	Uncountable Data 2016, San Francisco (United States), Series A	Developer of a unified platform for research and development data management	$27M	Sageview Capital, MK Capital & 4 others	61/100
8th	Synthace 2011, London (United Kingdom), Series C	Developer of software for automating biological experiments and data analysis	$80.3M	Horizons Ventures, Sofinnova Partners & 56 others	59/100
9th	Elemental Machines 2015, Cambridge (United States), Series B	Provider of data driven drug discovery and development platform for various industries	$52.3M	Omega Venture Partners, Founders Fund & 22 others	57/100
10th	Labvantage 1989, Somerset (United States), Funding Raised	Laboratory informatics platform streamlining lab data for informed business decisions	-	Bregal Sagemount, Apollo Investment Corporation ... & 2 others	54/100
14th	Emerald Therapeutics 2010, San Francisco (United States), Series C	Cloud-based remote laboratory automation software for the life sciences industry	$39.5M	Western Technology Investment, VII Ventures ... & 12 others	53/100